Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ATBPF | AKTX | MBRX | ||
Company | Antibe Therapeutics Inc | Akari Therapeutics ADR | Moleculin Biotech CS | ||
Price Information | |||||
Exchange | OTC US | NASDAQ | NASDAQ | ||
Open | 0.2328 | 1.5400 | 5.00 | ||
High | 0.2452 | 1.8541 | 5.47 | ||
Low | 0.1889 | 1.5136 | 4.99 | ||
Last | 0.2156 | 1.7000 | 5.06 | ||
Change | +0.0256 | +0.1600 | +0.04 | ||
% Change | +13.47% | +10.39% | +0.80% | ||
Volume | 33,900 | 165,100 | 29,400 | ||
20-Day Average Volume | 41,625 | 21,785 | 24,305 | ||
Previous Close | 0.1900 | 1.5400 | 5.02 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.2805 | 1.2751 | 4.74 | ||
20-Day Raw Stochastic | 40.74% | 80.16% | 47.85% | ||
20-Day Relative Strength | 34.47% | 54.50% | 43.88% | ||
Weighted Alpha | +1.76 | -61.27 | -56.30 | ||
Today's Opinion | 56% Sell | 72% Sell | 88% Sell | ||
Previous Opinion | 56% Sell | 80% Sell | 88% Sell | ||
Last Month's Opinion | 8% Sell | 100% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +86.99% since 04/01/24 | +42.86% since 04/24/24 | +16.32% since 04/24/24 | ||
Low | 0.1113 on 04/02/24 | 1.1700 on 04/26/24 | 4.28 on 04/25/24 | ||
High | 0.2452 on 04/08/24 | 1.8541 on 05/01/24 | 5.47 on 05/01/24 | ||
1-Month | |||||
%Chg | -36.00% since 03/08/24 | +12.58% since 04/01/24 | -10.76% since 04/01/24 | ||
Low | 0.1113 on 04/02/24 | 1.0775 on 04/17/24 | 4.28 on 04/25/24 | ||
High | 0.3582 on 03/13/24 | 1.8541 on 05/01/24 | 5.91 on 04/10/24 | ||
3-Month | |||||
%Chg | -74.24% since 01/08/24 | -34.94% since 02/01/24 | -34.75% since 02/01/24 | ||
Low | 0.1113 on 04/02/24 | 1.0775 on 04/17/24 | 4.28 on 04/25/24 | ||
High | 0.8122 on 01/09/24 | 2.7400 on 02/02/24 | 10.35 on 03/11/24 | ||
6-Month | |||||
%Chg | -35.64% since 10/04/23 | -52.65% since 11/01/23 | -30.01% since 11/01/23 | ||
Low | 0.1113 on 04/02/24 | 1.0775 on 04/17/24 | 4.28 on 04/25/24 | ||
High | 0.8855 on 11/09/23 | 3.6850 on 11/06/23 | 15.75 on 01/03/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 11,423 | 12,202 | 11,182 | ||
Shares Outstanding, K | 52,981 | 7,924 | 2,227 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -14,730,000 | -10,010,000 | -29,770,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -3,090,000 | -5,680,000 | -10,270,000 | ||
60-Month Beta | 0.51 | 0.96 | 1.95 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.06 on 02/14/24 | N/A on 09/27/22 | -2.85 on 11/13/23 | ||
Latest Earnings Date | 02/13/24 | 05/06/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |